PMID- 23182421 OWN - NLM STAT- MEDLINE DCOM- 20130607 LR - 20211021 IS - 1879-1379 (Electronic) IS - 0022-3956 (Print) IS - 0022-3956 (Linking) VI - 47 IP - 2 DP - 2013 Feb TI - Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course. PG - 252-8 LID - S0022-3956(12)00328-7 [pii] LID - 10.1016/j.jpsychires.2012.10.015 [doi] AB - BACKGROUND: Gene-environment interactions may contribute to bipolar disorder (BD) clinical course variability. We examined effects of brain-derived neurotrophic factor (BDNF) val66met genotype and early life stress (ELS) upon illness severity and chronicity in adult BD patients. METHODS: 80 patients (43 BD I, 33 BD II, 4 BD not otherwise specified, mean +/- SD age 46.4 +/- 14.0 years, 63.7% female) receiving open evidence-based and measurement-based care in the Stanford Bipolar Disorders Clinic for at least 12 months underwent BDNF val66met genotyping and completed the Childhood Trauma Questionnaire. BDNF met allele carrier genotype and history of childhood sexual and physical abuse were evaluated in relation to mean prior-year Clinical Global Impressions-Bipolar Version-Overall Severity of Illness (MPY-CGI-BP-OS) score and clinical and demographic characteristics. RESULTS: BDNF met allele carriers (but not non-met allele carriers) with compared to without childhood sexual abuse had 21% higher MPY-CGI-BP-OS scores (3.5 +/- 0.7 versus 2.9 +/- 0.7, respectively, t = -2.4, df = 28, p = 0.025) and 35% earlier BD onset age (14.6 +/- 5.7 versus 22.8 +/- 7.9 years, respectively, t = 3.0, df = 27, p = 0.006). Regression analysis, however, was non-significant for a BDNF-childhood sexual abuse interaction. LIMITATIONS: small sample of predominantly female Caucasian insured outpatients taking complex medication regimens; only one gene polymorphism considered. CONCLUSIONS: Between group comparisons suggested BDNF met allele carrier genotype might amplify negative effects of ELS upon BD illness severity/chronicity, although with regression analysis, there was not a significant gene-environment interaction. Further studies with larger samples are warranted to assess whether BDNF met allele carriers with ELS are at risk for more severe/chronic BD illness course. CI - Published by Elsevier Ltd. FAU - Miller, Shefali AU - Miller S AD - Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, USA. shefalis@stanford.edu FAU - Hallmayer, Joachim AU - Hallmayer J FAU - Wang, Po W AU - Wang PW FAU - Hill, Shelley J AU - Hill SJ FAU - Johnson, Sheri L AU - Johnson SL FAU - Ketter, Terence A AU - Ketter TA LA - eng GR - L30 MH091787/MH/NIMH NIH HHS/United States GR - T32 MH019938/MH/NIMH NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20121123 PL - England TA - J Psychiatr Res JT - Journal of psychiatric research JID - 0376331 RN - 0 (Brain-Derived Neurotrophic Factor) RN - AE28F7PNPL (Methionine) RN - HG18B9YRS7 (Valine) SB - IM MH - Adult MH - Bipolar Disorder/etiology/*genetics MH - Brain-Derived Neurotrophic Factor/*genetics MH - Female MH - Genetic Predisposition to Disease/*genetics MH - Genotype MH - Humans MH - Male MH - Methionine/*genetics MH - Middle Aged MH - Polymorphism, Single Nucleotide/*genetics MH - Psychiatric Status Rating Scales MH - Stress, Psychological/complications/genetics MH - Valine/*genetics PMC - PMC3529984 MID - NIHMS419382 EDAT- 2012/11/28 06:00 MHDA- 2013/06/08 06:00 PMCR- 2014/02/01 CRDT- 2012/11/28 06:00 PHST- 2012/06/28 00:00 [received] PHST- 2012/10/12 00:00 [revised] PHST- 2012/10/24 00:00 [accepted] PHST- 2012/11/28 06:00 [entrez] PHST- 2012/11/28 06:00 [pubmed] PHST- 2013/06/08 06:00 [medline] PHST- 2014/02/01 00:00 [pmc-release] AID - S0022-3956(12)00328-7 [pii] AID - 10.1016/j.jpsychires.2012.10.015 [doi] PST - ppublish SO - J Psychiatr Res. 2013 Feb;47(2):252-8. doi: 10.1016/j.jpsychires.2012.10.015. Epub 2012 Nov 23.